The primary focus of this paper is to evaluate how pharmaceutical organisations in the United Kingdom deliver Joint Working initiatives in partnership with the healthcare service. Joint Working represents the most formalised and transparent mechanism for cooperation between the industry and the National Health Service (NHS). The research evaluates the level of capability that organisations ‘desire’ to deliver collaborative initiatives, and the degree to which they possess the competencies to deliver them. A pilot study is conducted that adopts a mixed method research approach using secondary data and focus group analyses, interviews, and a survey. The findings present a comprehensive range of benefits that would appear to represent a compelling rationale for enhanced capability in Joint Working within the healthcare sector
